Hirokazu Katayama
- Molecular Biology
- Pharmaceutical Science top 5%
- Biomaterials
- Pulmonary and Respiratory Medicine
- Pediatrics, Perinatology and Child Health
- Co-authors
- Motoko KankeMikihisa TakanoRyoko YumotoJunya NagaiHironori YoshitomiMasato YasuharaRyohei HoriKatsuhiko Okumura
- Topics
- Metabolism and Genetic Disorders (5 papers)Advanced Drug Delivery Systems (5 papers)Amino Acid Enzymes and Metabolism (3 papers)
- Journals
- The Journal of Physical Chemistry CBiochemical PharmacologyEuropean Journal of Pharmacology
- Partner nations
- JapanCzechiaUnited States
In The Last Decade
Hirokazu Katayama
29 papers receiving 379 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 109
- Pharmaceutical Science 84
- Biomaterials 66
- Pulmonary and Respiratory Medicine 55
- Pediatrics, Perinatology and Child Health 44
Countries citing papers authored by Hirokazu Katayama
This map shows the geographic impact of Hirokazu Katayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Katayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Katayama more than expected).
Fields of papers citing papers by Hirokazu Katayama
This network shows the impact of papers produced by Hirokazu Katayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Katayama. The network helps show where Hirokazu Katayama may publish in the future.
Co-authorship network of co-authors of Hirokazu Katayama
This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Katayama. A scholar is included among the top collaborators of Hirokazu Katayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Katayama. Hirokazu Katayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 5 | |
| 3 | 16 | |
| 4 | 7 | |
| 5 | 89 | |
| 6 | 17 | |
| 7 | 1 | |
| 8 | 41 | |
| 9 | 4 | |
| 10 | 17 | |
| 11 | 1 | |
| 12 | 20 | |
| 13 | 1 | |
| 14 | 19 | |
| 15 | 5 | |
| 16 | 1 | |
| 17 | 12 | |
| 18 | 26 | |
| 19 | 2 | |
| 20 | 9 |
About Hirokazu Katayama
Hirokazu Katayama is a scholar working on Pharmaceutical Science, Clinical Biochemistry and Biochemistry, having authored 30 papers that have together received 398 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (5 papers), Advanced Drug Delivery Systems (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). The work is most often cited by research in Pharmaceutical Science (84 citations), Biomaterials (66 citations) and Pharmacology (39 citations). Hirokazu Katayama has collaborated with scholars based in Japan, Czechia and United States. Frequent co-authors include Motoko Kanke, Mikihisa Takano, Ryoko Yumoto, Junya Nagai, Hironori Yoshitomi, Masato Yasuhara, Ryohei Hori, Katsuhiko Okumura, Junko Fujiwara and Yasuo Kitagawa. Their work appears in journals such as The Journal of Physical Chemistry C, Biochemical Pharmacology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.